Beat the Blues: Treating Depression in African American Elders

Sponsor
Thomas Jefferson University (Other)
Overall Status
Completed
CT.gov ID
NCT00511680
Collaborator
(none)
192
1
1
45
4.3

Study Details

Study Description

Brief Summary

The specific primary aims of the study are to:
  1. Test the immediate effect of the intervention at 4-months on depression in urban African
American older adults (primary trial outcome; between group comparison). Hypothesis:

Participants in the intervention group will report fewer depressive symptoms in comparison to control group participants receiving usual care.

  1. Test the maintenance effect of the intervention at 8-months on depression (within group comparison). Hypothesis: Participants in the intervention group will maintain reduced symptom presentation from 4 to 8 months.

  2. Evaluate acceptability (social validity) of the intervention and extent of engagement in activities by study participants (both intervention and wait-list control subjects).

A secondary aim of this study is to assess the feasibility of conducting a clinical trial embedded in a community service setting and its dissemination using a community-academic partnership. We also propose three exploratory aims. First, we seek to evaluate the mechanisms of action, or pathways, by which treatment gains are obtained (Gitlin et al., 2000). Given that behavioral activation represents conceptually the key active ingredient of the proposed intervention, we plan to evaluate its mediational effect. Second, we seek to evaluate whether the intervention has a differential treatment effect based on a study participant's gender, age, and living arrangement (alone or with others). Given that previous research suggests that participant characteristics may moderate depressive symptoms and treatment outcomes, these exploratory analyses will provide insight as to whether this particular treatment benefits some groups more than others. Third, we seek to evaluate whether the intervention has short and long-term effects on quality of life, functional difficulty, and self-efficacy to manage day-to-day tasks. Previous research has shown that depressive symptoms exacerbate functional decline such that minimizing distress may have the added value of enhancing function and perceived efficacy for this group over time.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral Based In-Home Intervention
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
192 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Investigator)
Official Title:
Treating Depression in African American Elders: A Community-Academic Partnership
Study Start Date :
Sep 1, 2008
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral based In-home Intervention

This group will recieve up to 10 1-hour sessions over a 4 month period.

Behavioral: Behavioral Based In-Home Intervention
The 10 session intervention delivered by a social worker in the home includes five treatment components (education, referral, care management, stress reduction, behavioral activation). Each component has been shown to be effective in treating depression in previous research.

Outcome Measures

Primary Outcome Measures

  1. Depression [Baseline, t2, t3]

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • African American

  • ≥55 years of age

  • English speaking

  • Cognitively intact (MMSE >24)

  • Depressed as measured by a score ≥5 on the PHQ-9

  • Must have a telephone

  • Planning to live in the area for 8 months

Exclusion Criteria:
  • Not African American

  • <55 years of age

  • Does not speak English

  • MMSE<24

  • Not depressed as measures by a score of <5 on the PHQ-9

  • Does not have a telephone

  • Does not plan to live in the area for 8 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Thomas Jefferson University Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Thomas Jefferson University

Investigators

  • Principal Investigator: Laura N. Gitlin, Ph.D, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laura N. Gitlin, Director, Center for Innovative Care in Aging, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00511680
Other Study ID Numbers:
  • 1R01MH079814
First Posted:
Aug 6, 2007
Last Update Posted:
Aug 8, 2012
Last Verified:
Aug 1, 2012
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2012